Skip to main content
SpringerLink
Log in
Book cover

Pancreatic Masses pp 11–20Cite as

Pancreatic Adenocarcinoma

  • Chapter

  • 1204 Accesses

Abstract

Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States. Mortality from adenocarcinoma remains high despite decades of effort with regards to basic and clinical research. The biology of this disease is complex, and both inherited and environmental risk factors play a role in the pathogenesis and progression from precursor lesions to invasive carcinoma. Surgery remains the only curative option, but less than 20 % of patients are candidates for resection at the time of diagnosis. As such, a multidisciplinary approach focused not only on curative therapy, but also on palliative care and symptom control, constitutes import aspects of the management of pancreatic adenocarcinoma. In the future, the early identification of precursor lesions among high-risk individuals will hopefully improve mortality from this fatal disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  2. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al., editors. SEER cancer statistics review (CSR) 1975–2010. Bethesda: National Cancer Institute.

    Google Scholar 

  3. Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Di Magliano MP, Logsdon CD. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology. 2013;144(6):1220–9.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988;53(4):549–54.

    Article  CAS  PubMed  Google Scholar 

  6. Iacobuzio-Donahue CA. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut. 2012;61(7):1085–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Rall CJ, Yan YX, Graeme-Cook F, Beauchamp R, Yandell DW, Povoski SP, et al. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Pancreas. 1996;12(1):10–7.

    Article  CAS  PubMed  Google Scholar 

  8. Wood LD, Hruban RH. Pathology and molecular genetics of pancreatic neoplasms. Cancer J. 2012;18(6):492–501.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol. 1993;142(5):1534.

    PubMed Central  CAS  PubMed  Google Scholar 

  10. Hahn SA, Schutte M, Hoque AS, Moskaluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271(5247):350–3.

    Article  CAS  PubMed  Google Scholar 

  11. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, et al. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res. 2009;15(14):4674–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605–17.

    Article  CAS  PubMed  Google Scholar 

  13. Feldmann G, Beaty R, Hruban RH, Maitra A. Molecular genetics of pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Surg. 2007;14(3):224–32.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Lucas AL, Chang MM, Lipsyc MD, Frucht H. The prevention and genetics of pancreatic cancer: a programmatic approach. In: Su GH, editor. Pancreatic cancer—methods and protocols. 2nd ed. New York: Springer; 2013.

    Google Scholar 

  15. Solomon S, Das S, Brand R, Whitcomb DC. Inherited pancreatic cancer syndromes. Cancer J. 2012;18(6):485–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010;139(4):1076–80.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009;302(16):1790–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology. 2000;119(6):1447–53.

    Article  CAS  PubMed  Google Scholar 

  19. Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical multiple mole melanoma-pancreatic carcinoma syndrome. Cancer. 2002;94(1):84–96.

    Article  CAS  PubMed  Google Scholar 

  20. Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer. 2000;87(6):809–11.

    Article  CAS  PubMed  Google Scholar 

  21. Consortium TBCL. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310–6.

    Article  Google Scholar 

  22. Ferrone CR, Levine DA, Tang LH, Allen PJ, Jarnagin W, Brennan MF, et al. BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J Clin Oncol. 2009;27(3):433–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993;34(10):1394–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14(2):141–5.

    Article  CAS  PubMed  Google Scholar 

  25. Rebours V, Lévy P, Ruszniewski P. An overview of hereditary pancreatitis. Dig Liver Dis. 2012;44(1):8–15.

    Article  CAS  PubMed  Google Scholar 

  26. Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S, et al. An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 2012;122(4):1519–28.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1–2):349–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 2001;286(2):169–70.

    Article  CAS  PubMed  Google Scholar 

  29. Rebours V, Boutron-Ruault M-C, Jooste V, Bouvier A-M, Hammel P, Ruszniewski P, et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses. Am J Gastroenterol. 2009;104(9):2312–7.

    Article  PubMed  Google Scholar 

  30. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4–5):645–56.

    Article  PubMed  Google Scholar 

  31. Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012;23(7):1880–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011;47(13):1928–37.

    Article  PubMed  Google Scholar 

  33. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076–83.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Aune D, Greenwood DC, Chan DSM, Vieira R, Vieira AR, Navarro Rosenblatt DA, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843–52.

    Article  CAS  PubMed  Google Scholar 

  35. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120(9):1993–8.

    Article  CAS  PubMed  Google Scholar 

  36. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu X-O, Steplowski E, Bueno-de-Mesquita HB, et al. Anthropometric measures, body mass index and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170(9):791–802.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009;301(24):2553–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010;126(6):1474–86.

    CAS  PubMed  Google Scholar 

  39. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, et al. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012;23(11):2964–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst. 2010;102(7):502–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223(5):506–11; discussion 511–2.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7(5):189–97.

    Article  PubMed  Google Scholar 

  43. Smith TA, Brand EJ. Pancreatic cancer presenting as bleeding gastric varices. J Clin Gastroenterol. 2001;32(5):444–7.

    Article  CAS  PubMed  Google Scholar 

  44. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10(1):88–95.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Tummala P, Tariq SH, Chibnall JT, Agarwal B. Clinical predictors of pancreatic carcinoma causing acute pancreatitis. Pancreas. 2013;42(1):108–13.

    Article  PubMed  Google Scholar 

  46. Wong YT, Brams DM, Munson L, Sanders L, Heiss F, Chase M, et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc. 2002;16(2):310–2.

    Article  CAS  PubMed  Google Scholar 

  47. Park JW, Jang J-Y, Kim E-J, Kang MJ, Kwon W, Chang YR, et al. Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg. 2013;100(8):1064–70.

    Article  CAS  PubMed  Google Scholar 

  48. Muniraj T, Chari S. Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol. 2012;58(4):331–45.

    PubMed Central  CAS  PubMed  Google Scholar 

  49. Winter JM, Yeo CJ, Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol. 2013;107(1):15–22.

    Article  PubMed  Google Scholar 

  50. Glenn J, Steinberg WM, Kurtzman SH, Steinberg SM, Sindelar WF. Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas. J Clin Oncol. 1988;6(3):462–8.

    CAS  PubMed  Google Scholar 

  51. Pleskow DK, Berger HJ, Gyves J, Allen E, McLean A, Podolsky DK. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med. 1989;110(9):704–9.

    Article  CAS  PubMed  Google Scholar 

  52. Berger AC, Garcia Jr M, Hoffman JP, Regine WF, Abrams RA, Safran H, et al. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008;26(36):5918–22.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Turrini O, Schmidt CM, Moreno J, Parikh P, Matos JM, House MG, et al. Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy? J Gastrointest Surg. 2009;13(10):1791–7.

    Article  CAS  PubMed  Google Scholar 

  54. Haglund C. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. Br J Cancer. 1986;54(6):897–901.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Benini L, Cavallini G, Zordan D, Rizzotti P, Rigo L, Brocco G, et al. A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. Pancreas. 1988;3(1):61–6.

    Article  CAS  PubMed  Google Scholar 

  56. Hruban RH, Pitman MB, Klimstra DS, editors. Tumors of the pancreas. Atlas of tumor pathology. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2007.

    Google Scholar 

  57. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol. 2008;3:157–88.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418–29.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  59. Edge S, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. New York: Springer; 2010.

    Google Scholar 

  60. Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK, editors. Exocrine and endocrine pancreas. AJCC cancer staging atlas. New York: Springer; 2012. p. 297–308.

    Google Scholar 

  61. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, et al. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer. 2007;110(4):738–44.

    Article  PubMed  Google Scholar 

  62. Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23(30):7529–35.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Wasif N, Ko CY, Farrell J, Wainberg Z, Hines OJ, Reber H, et al. Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010;17(9):2312–20.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Rochefort MM, Ankeny JS, Kadera BE, Donald GW, Isacoff W, Wainberg ZA, et al. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Ann Surg Oncol. 2013;20(13):4322–9.

    Article  PubMed  Google Scholar 

  65. Pawlik TM, Laheru D, Hruban RH, Coleman J, Wolfgang CL, Campbell K, et al. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol. 2008;15(8):2081–8.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Katz MHG, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(4):836–47.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142(4):796–804; quiz e14–5.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut. 2009;58(10):1410–8.

    Article  CAS  PubMed  Google Scholar 

  69. Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley J-W, Kamel I, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339–47.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1069, New York, NY, 10029, USA

    Sunil Amin M.D., M.P.H. & Christopher J. DiMaio M.D.

Authors
  1. Sunil Amin M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher J. DiMaio M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J. DiMaio M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology, University of Florida, Gainesville, Florida, USA

    Mihir S. Wagh

  2. Division of Gastroenterology, University of Florida, Gainesville, Florida, USA

    Peter V. Draganov

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Amin, S., DiMaio, C.J. (2016). Pancreatic Adenocarcinoma. In: Wagh, M., Draganov, P. (eds) Pancreatic Masses. Springer, Cham. https://doi.org/10.1007/978-3-319-19677-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19677-0_2

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19676-3

  • Online ISBN: 978-3-319-19677-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation